1. Home
  2. WST vs ASX Comparison

WST vs ASX Comparison

Compare WST & ASX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • ASX
  • Stock Information
  • Founded
  • WST 1923
  • ASX 1984
  • Country
  • WST United States
  • ASX Taiwan
  • Employees
  • WST N/A
  • ASX N/A
  • Industry
  • WST Medical/Dental Instruments
  • ASX Semiconductors
  • Sector
  • WST Health Care
  • ASX Technology
  • Exchange
  • WST Nasdaq
  • ASX Nasdaq
  • Market Cap
  • WST 23.2B
  • ASX 22.5B
  • IPO Year
  • WST N/A
  • ASX 1995
  • Fundamental
  • Price
  • WST $322.46
  • ASX $10.19
  • Analyst Decision
  • WST Buy
  • ASX Strong Buy
  • Analyst Count
  • WST 3
  • ASX 1
  • Target Price
  • WST $460.33
  • ASX N/A
  • AVG Volume (30 Days)
  • WST 514.2K
  • ASX 6.8M
  • Earning Date
  • WST 10-24-2024
  • ASX 01-30-2025
  • Dividend Yield
  • WST 0.26%
  • ASX 3.16%
  • EPS Growth
  • WST N/A
  • ASX N/A
  • EPS
  • WST 6.74
  • ASX 0.23
  • Revenue
  • WST $2,876,400,000.00
  • ASX $18,693,593,707.00
  • Revenue This Year
  • WST N/A
  • ASX $6.13
  • Revenue Next Year
  • WST $6.22
  • ASX $14.78
  • P/E Ratio
  • WST $47.61
  • ASX $20.87
  • Revenue Growth
  • WST N/A
  • ASX N/A
  • 52 Week Low
  • WST $265.00
  • ASX $8.10
  • 52 Week High
  • WST $413.70
  • ASX $12.86
  • Technical
  • Relative Strength Index (RSI)
  • WST 53.52
  • ASX 57.61
  • Support Level
  • WST $313.92
  • ASX $9.84
  • Resistance Level
  • WST $326.58
  • ASX $10.09
  • Average True Range (ATR)
  • WST 7.66
  • ASX 0.20
  • MACD
  • WST -0.61
  • ASX 0.05
  • Stochastic Oscillator
  • WST 84.86
  • ASX 99.43

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About ASX ASE Technology Holding Co. Ltd. (each representing Two)

ASE Technology Holding Co Ltd is a semiconductor assembly and testing firm. The company operates in segments: Packaging, Testing, and Electronic Manufacturing Services. Of these, Electronic Manufacturing Services contribute the maximum revenue. The packaging segment involves packaging bare semiconductors into completed semiconductors with improved electrical and thermal characteristics. The Testing Segment includes front-end engineering testing, wafer probing, and final testing services. In the EMS segment, the company designs manufactures, and sells electronic components and telecommunication equipment motherboards. The company is based in Taiwan but garners over half its sales from firms in the United States.

Share on Social Networks: